{"pmid":32317205,"title":"Clinical features and multidisciplinary treatment outcome of COVID-19 pneumonia: A report of three cases.","text":["Clinical features and multidisciplinary treatment outcome of COVID-19 pneumonia: A report of three cases.","The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic threatening global public health. In the current paper, we describe our successful treatment of three COVID-19 pneumonia patients cases including severe cases and cases with mortality risk factors. One 32-year-old male COVID-19 patient was diagnosed with severe COVID-19 pneumonia and moderate ARDS. The second COVID-19 pneumonia patient had a history of diabetes and chronic bronchitis. The third case of COVID-19 pneumonia was an 82-year old female patient. All three cases had severe COVID pneumonia and therefore were aggressively managed with a multidisciplinary and personalized therapeutic approach that included nutritional support, antiviral pharmacotherapy, active control of comorbidities, prevention of complication development and psychological intervention. Our experience highlights the importance of the use of a multidisciplinary therapeutic approach that tailors to the specific condition of the patient in achieving a favorable clinical outcome.","J Formos Med Assoc","Liu, Chun","Wu, Changhui","Zheng, Xiangde","Zeng, Fanwei","Liu, Jinping","Wang, Pingxi","Zeng, Fanxin","Yuan, Lin","Zhu, Fangcheng","Gan, Xuemei","Huang, Yucheng","32317205"],"abstract":["The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic threatening global public health. In the current paper, we describe our successful treatment of three COVID-19 pneumonia patients cases including severe cases and cases with mortality risk factors. One 32-year-old male COVID-19 patient was diagnosed with severe COVID-19 pneumonia and moderate ARDS. The second COVID-19 pneumonia patient had a history of diabetes and chronic bronchitis. The third case of COVID-19 pneumonia was an 82-year old female patient. All three cases had severe COVID pneumonia and therefore were aggressively managed with a multidisciplinary and personalized therapeutic approach that included nutritional support, antiviral pharmacotherapy, active control of comorbidities, prevention of complication development and psychological intervention. Our experience highlights the importance of the use of a multidisciplinary therapeutic approach that tailors to the specific condition of the patient in achieving a favorable clinical outcome."],"journal":"J Formos Med Assoc","authors":["Liu, Chun","Wu, Changhui","Zheng, Xiangde","Zeng, Fanwei","Liu, Jinping","Wang, Pingxi","Zeng, Fanxin","Yuan, Lin","Zhu, Fangcheng","Gan, Xuemei","Huang, Yucheng"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32317205","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jfma.2020.04.008","keywords":["covid-19","multidisciplinary therapeutic approach","sars-cov-2"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664815087638020096,"score":8.518259,"similar":[{"pmid":32233973,"title":"Implications for Online Management: Two Cases with COVID-19.","text":["Implications for Online Management: Two Cases with COVID-19.","Satisfactory outcome was observed in one mild case and one severe case of COVID-19 pneumonia after the use of the online/offline multidisciplinary quarantine observation form, online monitoring, and classified diagnosis and treatment, as well as strict compliance with quarantine measures. Conditions of both patients were improved, and cross-infection and disease onset clustering were not observed. The multidisciplinary self-quarantine model provides early judgment, identification, and treatment of disease, improves compliance with early rehabilitation, increases confidence in recovery, and enhances self-management capabilities. This model is applicable to the current novel coronavirus pneumonia epidemic and can actively promote the management of suspected or confirmed mild cases, monitoring of critical cases, and self-management of discharged patients. The application of this new management model is worthy of being promoted in our specialized treatment facilities and in countries with severe epidemics.","Telemed J E Health","Huang, Sufang","Xiao, Yaru","Yan, Li","Deng, Juan","He, Mei","Lu, Jun","Ke, Shun","32233973"],"abstract":["Satisfactory outcome was observed in one mild case and one severe case of COVID-19 pneumonia after the use of the online/offline multidisciplinary quarantine observation form, online monitoring, and classified diagnosis and treatment, as well as strict compliance with quarantine measures. Conditions of both patients were improved, and cross-infection and disease onset clustering were not observed. The multidisciplinary self-quarantine model provides early judgment, identification, and treatment of disease, improves compliance with early rehabilitation, increases confidence in recovery, and enhances self-management capabilities. This model is applicable to the current novel coronavirus pneumonia epidemic and can actively promote the management of suspected or confirmed mild cases, monitoring of critical cases, and self-management of discharged patients. The application of this new management model is worthy of being promoted in our specialized treatment facilities and in countries with severe epidemics."],"journal":"Telemed J E Health","authors":["Huang, Sufang","Xiao, Yaru","Yan, Li","Deng, Juan","He, Mei","Lu, Jun","Ke, Shun"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32233973","week":"202014|Mar 30 - Apr 05","doi":"10.1089/tmj.2020.0066","keywords":["e-health","multidisciplinary collaboration","novel coronavirus pneumonia","online management","quarantine","self-management","telemedicine"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664638354222743554,"score":245.1457},{"pmid":32282991,"title":"Immunosuppressive therapy maintenance in a kidney transplant recipient SARS-CoV-2 pneumonia: a case report.","text":["Immunosuppressive therapy maintenance in a kidney transplant recipient SARS-CoV-2 pneumonia: a case report.","The role of systemic inflammation is proving crucial in determining unfavorable outcome in SARS-CoV-2 infected patients. Limited data are available regarding immunosuppression management in kidney transplant recipients (KTRs) with SARS-CoV-2 pneumonia. We report a case of a 32-year-old KTR who developed SARS-CoV-2 infection and fully recovered in 15 days while maintaining standard immunosuppressive therapy.","Am J Transplant","Bussalino, Elisabetta","De Maria, Andrea","Russo, Rodolfo","Paoletti, Ernesto","32282991"],"abstract":["The role of systemic inflammation is proving crucial in determining unfavorable outcome in SARS-CoV-2 infected patients. Limited data are available regarding immunosuppression management in kidney transplant recipients (KTRs) with SARS-CoV-2 pneumonia. We report a case of a 32-year-old KTR who developed SARS-CoV-2 infection and fully recovered in 15 days while maintaining standard immunosuppressive therapy."],"journal":"Am J Transplant","authors":["Bussalino, Elisabetta","De Maria, Andrea","Russo, Rodolfo","Paoletti, Ernesto"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32282991","week":"202016|Apr 13 - Apr 19","doi":"10.1111/ajt.15920","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664636704058769411,"score":245.09532},{"pmid":32186172,"title":"[Thoughts and practice on the treatment of severe and critical new coronavirus pneumonia].","text":["[Thoughts and practice on the treatment of severe and critical new coronavirus pneumonia].","Severe and critical coronavirus pneumonia 2019 (COVID-19) often occurs in elder patients with multiple comorbidities, and severe hypoxemia events are an important factor in the deterioration of some cases. The critical type of COVID-19 could progress to acute respiratory distress syndrome and multi-organ dysfunction, which are the most important causes of death. Early start with non-invasive ventilation (NIV) against the possible physiological abnormalities could be helpful to improve prognosis. Close monitoring of oxygenation, reducing patients' oxygen consumption, active psychological intervention, and rapidly dealing with severe hypoxemia events are the key factors for the successful treatment of NIV. In addition, active adjuvant therapy is also important, such as correcting coagulation dysfunction, providing proper nutritional support, accurate volume control, and safe individualized blood glucose monitoring and control.","Zhonghua Jie He He Hu Xi Za Zhi","Li, H C","Ma, J","Zhang, H","Cheng, Y","Wang, X","Hu, Z W","Li, N","Deng, X R","Zhang, Y","Zheng, X Z","Yang, F","Weng, H Y","Dong, J P","Liu, J W","Wang, Y Y","Liu, X M","32186172"],"abstract":["Severe and critical coronavirus pneumonia 2019 (COVID-19) often occurs in elder patients with multiple comorbidities, and severe hypoxemia events are an important factor in the deterioration of some cases. The critical type of COVID-19 could progress to acute respiratory distress syndrome and multi-organ dysfunction, which are the most important causes of death. Early start with non-invasive ventilation (NIV) against the possible physiological abnormalities could be helpful to improve prognosis. Close monitoring of oxygenation, reducing patients' oxygen consumption, active psychological intervention, and rapidly dealing with severe hypoxemia events are the key factors for the successful treatment of NIV. In addition, active adjuvant therapy is also important, such as correcting coagulation dysfunction, providing proper nutritional support, accurate volume control, and safe individualized blood glucose monitoring and control."],"journal":"Zhonghua Jie He He Hu Xi Za Zhi","authors":["Li, H C","Ma, J","Zhang, H","Cheng, Y","Wang, X","Hu, Z W","Li, N","Deng, X R","Zhang, Y","Zheng, X Z","Yang, F","Weng, H Y","Dong, J P","Liu, J W","Wang, Y Y","Liu, X M"],"date":"2020-03-19T11:00:00Z","year":2020,"_id":"32186172","week":"202012|Mar 16 - Mar 22","doi":"10.3760/cma.j.cn112147-20200312-00320","keywords":["covid-19","early intervention","non-invasive ventilation","very severe hypoxemia events","acute respiratory distress syndrome"],"source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Glucose"],"_version_":1664640874551705600,"score":241.37474},{"pmid":32286213,"title":"[Fatal outcome of coronavirus disease 2019 in a previously healthy 50-year-old man].","text":["[Fatal outcome of coronavirus disease 2019 in a previously healthy 50-year-old man].","In this case report, a 50-year-old man who had no medical history, presented with multiple cardiac arrests following a week with progressing symptoms of pneumonia. After achieving return of spontaneous circulation he presented with respiratory failure with severe hypoxia, septic shock, and multiple organ failure. A chest X-ray showed signs of acute respiratory distress syndrome. Despite aggressive intensive care management, the patient died 7.5 hours after admission. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was later confirmed, and the presumed cause of death was SARS-CoV-2 pneumonia. In conclusion: coronavirus disease 2019 (COVID-19) can lead to a fatal outcome in younger healthy residents, who are not treated timely in case of severe symptoms like dyspnoea.","Ugeskr Laeger","Wissenberg, Mads","Andersen, Lars Peter Kloster","Pallisgaard, Jannik Langtved","Lawson-Smith, Pia","32286213"],"abstract":["In this case report, a 50-year-old man who had no medical history, presented with multiple cardiac arrests following a week with progressing symptoms of pneumonia. After achieving return of spontaneous circulation he presented with respiratory failure with severe hypoxia, septic shock, and multiple organ failure. A chest X-ray showed signs of acute respiratory distress syndrome. Despite aggressive intensive care management, the patient died 7.5 hours after admission. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was later confirmed, and the presumed cause of death was SARS-CoV-2 pneumonia. In conclusion: coronavirus disease 2019 (COVID-19) can lead to a fatal outcome in younger healthy residents, who are not treated timely in case of severe symptoms like dyspnoea."],"journal":"Ugeskr Laeger","authors":["Wissenberg, Mads","Andersen, Lars Peter Kloster","Pallisgaard, Jannik Langtved","Lawson-Smith, Pia"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32286213","week":"202016|Apr 13 - Apr 19","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664636391631355904,"score":237.13443},{"pmid":32331519,"title":"Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin.","text":["Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin.","BACKGROUND: COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, including chloroquine. We report here the clinical features and therapeutic course of the first reported patient with confirmed COVID-19 pneumonia that recovered in Colombia, after the use of chloroquine and clarithromycin. CASE PRESENTATION: A 34-year-old male, returning from Spain, presented with complaints of fever, and cough, and class-II obesity, being hospitalized. The respiratory viruses and bacteria tested by FilmArray((R)) PCR were negative. Two days later, clarithromycin was started because the patient was suspected as community-acquired pneumonia. At the third day, the rRT-PCR confirmed the SARS-CoV-2 infection. A day later, chloroquine was started because of that. His chest computed tomography was performed and showed bilateral multifocal ground-glass opacities with consolidation, which suggested viral pneumonia as a differential diagnosis. Progressively his clinical condition improved and at day 9, patient rRT-PCR for SARS-CoV-2 became negative. The patient was discharged and isolated at home per 14 days. CONCLUSIONS: Our patient improved significantly. This and other COVID-19 cases are urgently demanding results from clinical trials that support evidence-based therapeutical approaches to this pandemic and the clinical management of patients, especially those at critical care.","Ann Clin Microbiol Antimicrob","Millan-Onate, Jose","Millan, William","Mendoza, Luis Alfonso","Sanchez, Carlos Guillermo","Fernandez-Suarez, Hugo","Bonilla-Aldana, D Katterine","Rodriguez-Morales, Alfonso J","32331519"],"abstract":["BACKGROUND: COVID-19 pandemics is a challenge for public health and infectious diseases clinicians, especially for the therapeutical approach that is not yet adequately defined. Amid this situation, investigational agents are being used, including chloroquine. We report here the clinical features and therapeutic course of the first reported patient with confirmed COVID-19 pneumonia that recovered in Colombia, after the use of chloroquine and clarithromycin. CASE PRESENTATION: A 34-year-old male, returning from Spain, presented with complaints of fever, and cough, and class-II obesity, being hospitalized. The respiratory viruses and bacteria tested by FilmArray((R)) PCR were negative. Two days later, clarithromycin was started because the patient was suspected as community-acquired pneumonia. At the third day, the rRT-PCR confirmed the SARS-CoV-2 infection. A day later, chloroquine was started because of that. His chest computed tomography was performed and showed bilateral multifocal ground-glass opacities with consolidation, which suggested viral pneumonia as a differential diagnosis. Progressively his clinical condition improved and at day 9, patient rRT-PCR for SARS-CoV-2 became negative. The patient was discharged and isolated at home per 14 days. CONCLUSIONS: Our patient improved significantly. This and other COVID-19 cases are urgently demanding results from clinical trials that support evidence-based therapeutical approaches to this pandemic and the clinical management of patients, especially those at critical care."],"journal":"Ann Clin Microbiol Antimicrob","authors":["Millan-Onate, Jose","Millan, William","Mendoza, Luis Alfonso","Sanchez, Carlos Guillermo","Fernandez-Suarez, Hugo","Bonilla-Aldana, D Katterine","Rodriguez-Morales, Alfonso J"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32331519","week":"202017|Apr 20 - Apr 26","doi":"10.1186/s12941-020-00358-y","keywords":["chloroquine","colombia","coronavirus disease 2019 (covid-19)","latin america","severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"],"source":"PubMed","topics":["Case Report"],"weight":1,"locations":["Colombia","Spain","Colombia"],"countries":["Spain","Colombia"],"countries_codes":["ESP|Spain","COL|Colombia"],"e_drugs":["Clarithromycin","Chloroquine"],"_version_":1665071049689006080,"score":226.40233}]}